feprazone has been researched along with ENT Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppi, G | 1 |
| Cremonesi, G; Stura, M; Tarantino, V | 1 |
2 trial(s) available for feprazone and ENT Diseases
| Article | Year |
|---|---|
[Pharmacological and clinical profile of tiaprofenic acid].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Feprazone; Flurbiprofen; Guinea Pigs; Humans; Otorhinolaryngologic Diseases; Propionates; Rats; Sulfonamides | 1990 |
[Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Feprazone; Humans; Infant; Inflammation; Male; Nicotinic Acids; Niflumic Acid; Otorhinolaryngologic Diseases; Phenylbutazone; Random Allocation | 1985 |